Ann Intern Med. 2011 Mar 1;154(5):356-64. doi: 10.7326/0003-4819-154-5-201103010-00307. Epub 2011 Jan 17.
Update of the 2002 U.S. Preventive Services Task Force (USPSTF) recommendation on screening for osteoporosis.
The USPSTF evaluated evidence on the diagnostic accuracy of risk assessment instruments for osteoporosis and fractures, the performance of dual-energy x-ray absorptiometry and peripheral bone measurement tests in predicting fractures, the harms of screening for osteoporosis, and the benefits and harms of drug therapy for osteoporosis in women and men.
The USPSTF recommends screening for osteoporosis in women aged 65 years or older and in younger women whose fracture risk is equal to or greater than that of a 65-year-old white woman who has no additional risk factors. (Grade B recommendation) The USPSTF concludes that the current evidence is insufficient to assess the balance of benefits and harms of screening for osteoporosis in men. (I statement).
对 2002 年美国预防服务工作组（USPSTF）关于骨质疏松症筛查的建议进行更新。
USPSTF 评估了骨质疏松症和骨折风险评估工具的诊断准确性、双能 X 射线吸收测定法和外周骨测量试验在预测骨折方面的性能、骨质疏松症筛查的危害，以及药物治疗女性和男性骨质疏松症的益处和危害方面的证据。
USPSTF 建议对年龄在 65 岁及以上的女性和骨折风险等同于或大于无其他危险因素的 65 岁白人女性的年轻女性进行骨质疏松症筛查。（B 级推荐）USPSTF 得出结论，目前的证据不足以评估对男性进行骨质疏松症筛查的利弊平衡。（I 声明）
